Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Given Average Rating of "Hold" by Analysts

Retrieved on: 2021-01-12 06:21:24

Tags for this article:

Click the tags to see associated articles and topics

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Given Average Rating of "Hold" by Analysts. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 1,854,310 shares of the biopharmaceutical company's stock valued at $2,669,000 after buying an additional ...

Article found on: www.marketbeat.com